|U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North Carolina. (File photo by=CNA)|
[아시아뉴스통신=레악카나 기자] As scientists and pharmaceutical companies work at breakneck speed to develop a vaccine for the novel coronavirus, public health officials and senior US lawmakers are sounding alarms about the Trump administration's lack of planning for its nationwide distribution.
The federal government traditionally plays a principal role in funding and overseeing the manufacturing and distribution of new vaccines, which often draw on scarce ingredients and need to be made, stored and transported carefully.There won't be enough vaccines for all 330 million Americans right away, so the government also has a role in deciding who gets it first, and in educating a vaccine-wary public about its potential life saving merits.
Right now, it is unclear who in Washington is in charge of oversight, much less any critical details, some state health officials and members of Congress told Reuters.However, Dr Robert Redfield, director of the Centers for Disease Control and Prevention (CDC), told a Senate hearing on Jul 2 that his agency would spearhead the campaign to develop and distribute a vaccine for the new coronavirus.
"This is really the prime responsibility of CDC," he said. Some state public health officials, meanwhile, say their entreaties to the Trump administration have been unanswered.